Visceral and subcutaneous adipose tissue from lean women respond differently to lipopolysaccharide-induced alteration of inflammation and glyceroneogenesis

Nutrition and Diabetes

Volumn 2, Issue DECEMBER, 2012, Pages

  Vatier, C ^a,b   Kadiri, S ^a,b   Muscat, A ^a,b   Chapron, C ^c   Capeau, J ^a,b   Antoine, B ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Institut Cochin   (France)

Author keywords

Glyceroneogenesis; Inflammation; Lean human; LPS; Subcutaneous adipose tissue; Visceral adipose tissue

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EXPLANT; FATTY ACID SYNTHESIS; FEMALE; GENE EXPRESSION; GLYCERONEOGENESIS; HUMAN; HUMAN TISSUE; INFLAMMATION; INTRAABDOMINAL FAT; LIPID STORAGE; MACROPHAGE; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

EID: 84881138773     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2012.29     Document Type: Article

References (40)

1. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410-420.
2. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
3. Iozzo P. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care 2009; 32(Suppl 2): S168-S173.
4. Klimcakova E, Roussel B, Marquez-Quinones A, Kovacova Z, Kovacikova M, Combes M et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. J Clin Endocrinol Metab 2011; 96: E73-E82.
5. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131: 242-256.
6. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
7. Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther 2004; 9: 555-564.
8. Gandotra S, Le Dour C, Bottomley W, Cervera P, Giral P, Reznik Y et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 2011; 364: 740-748.
9. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
10. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008; 117: 806-815.
11. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A et al. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009; 94: 4619-4623.
12. Dasu MR, Jialal I. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors. Am J Physiol Endocrinol Metab 2011; 300: E145-E154.
13. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
14. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772.
15. Serino M, Luche E, Gres S, Baylac A, Berge M, Cenac C et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012; 61: 543-553.
16. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292: E740-E747.
17. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
18. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010; 61: 69-78.
19. Mehta NN, McGillicuddy FC, Anderson PD, Hinkle CC, Shah R, Pruscino L et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010; 59: 172-181.
20. Jensen MD. Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest 1995; 96: 2297-2303.
21. Jensen MD. Adipose tissue metabolism - an aspect we should not neglect? Horm Metab Res 2007; 39: 722-725.
22. Beale EG, Hammer RE, Antoine B, Forest C. Disregulated glyceroneogenesis: PCK1 as a candidate diabetes and obesity gene. Trends Endocrinol Metab 2004; 15: 129-135.
23. Millward CA, Desantis D, Hsieh CW, Heaney JD, Pisano S, Olswang Y et al. Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice. J Lipid Res 2010; 51: 1452-1463.
24. Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 2002; 51: 624-630.
25. Leroyer SN, Tordjman J, Chauvet G, Quette J, Chapron C, Forest C et al. Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation. J Biol Chem 2006; 281: 13141-13149.
26. Leroyer S, Vatier C, Kadiri S, Quette J, Chapron C, Capeau J et al. Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue. J Lipid Res 2011; 52: 207-220.
27. Ballard FJ, Hanson RW. Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase. J Biol Chem 1969; 244: 5625-5630.
28. Chang HC, Lane MD. The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase. J Biol Chem 1966; 241: 2413-2420.
29. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247.
30. Tam CS, Heilbronn LK, Henegar C, Wong M, Cowell CT, Cowley MJ et al. An early inflammatory gene profile in visceral adipose tissue in children. Int J Pediatr Obes 2011; 6: e360-e363.
31. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
32. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007; 31: 1420-1428.
33. Lassenius MI, Pietilainen KH, Kaartinen K, Pussinen PJ, Syrjanen J, Forsblom C et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 2011; 34: 1809-1815.
34. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 2011; 34: 392-397.
35. Bassols J, Ortega FJ, Moreno-Navarrete JM, Peral B, Ricart W, Fernandez-Real JM. Study of the proinflammatory role of human differentiated omental adipocytes. J Cell Biochem 2009; 107: 1107-1117.
36. Leuwer M, Welters I, Marx G, Rushton A, Bao H, Hunter L et al. Endotoxaemia leads to major increases in inflammatory adipokine gene expression in white adipose tissue of mice. Pflugers Arch 2009; 457: 731-741.
37. Osto M, Zini E, Franchini M, Wolfrum C, Guscetti F, Hafner M et al. Subacute endotoxemia induces adipose inflammation and changes in lipid and lipoprotein metabolism in cats. Endocrinology 2011; 152: 804-815.
38. Feingold KR, Moser A, Shigenaga JK, Grunfeld C. Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue. Innate Immun 2012; 18: 231-240.
39. Zhang J, Henagan TM, Gao Z, Ye J. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation. Endocrinology 2011; 152: 1829-1838.
40. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165.